复方五味子提取物对力竭游泳大鼠的抗疲劳作用

五味子、黄芪、丹参、枸杞和马齿苋均具有较好的抗氧化活性和抗疲劳功效。然而,尚不清楚该5种中药材组合的应用效果。本研究将这5种植物药材进行混合提取,得到了复方五味子提取物。然后考察了不同剂量的复方五味子提取物对力竭游泳大鼠的运动能力和生化指标的影响。研究显示,复方五味子提取物以剂量依赖性方式提高大鼠的力竭游泳时间(p<0.05)。复方五味子提取物以剂量依赖性方式降低血清Lac和BUN水平并升高NEFA水平(p<0.05)。复方五味子提取物显著升高大鼠体内SOD和CAT水平,并显著降低MDA水平(p<0.05)。复方五味子提取物显著降低大鼠血清CK、AST和ALT水平(p<0.05),并减弱骨骼肌组织病变程度。本研究表明,复方五味子提取物具有较好的抗疲劳作用,可通过减少乳酸堆积、增加脂肪动员、减弱氧化应激损伤来提高机体运动能力。     

白灵菇多糖对运动小鼠氧化应激的影响

体外研究表明,白灵菇多糖具有较高的清除自由基能力。然而,白灵菇多糖在体内对运动引起的氧化应激的影响尚不清楚。本研究将100只SPF级雄性昆明小鼠随机分为5组,低剂量组、中剂量组和高剂量组昆明小鼠分别按照50 mg·kg^-1·d^-1、100 mg·kg^-1·d^-1和200 mg·kg^-1·d^-1的剂量灌胃白灵菇多糖溶液,对照组和模型组昆明小鼠灌胃等体积的蒸馏水,连续灌胃4周。研究显示,白灵菇多糖溶液以浓度依赖性方式提高了小鼠的力竭游泳时间(p<0.05)。白灵菇多糖以浓度依赖性方式降低了小鼠血清AST、ALT和CK水平,并显著减少了骨骼肌的病理变化(p<0.05)。白灵菇多糖以剂量依赖方式升高力竭游泳小鼠体内SOD、CAT和GSH-PX水平,并降低了MDA水平(p<0.05)。此外,对小鼠灌胃白灵菇多糖可以剂量依赖方式提高小鼠血清总抗氧化活性(p<0.05)。上述研究表明,白灵菇多糖可有效提高力竭游泳小鼠的抗疲劳能力,减轻运动引起的心肌、肝脏、骨骼肌和氧化应激损伤,提高机体的抗氧化能力。     

不同剂量大豆蛋白对大鼠抗疲劳和运动能力的影响

大豆蛋白具有降低胆固醇、抗氧化、提高机体免疫等多种生物功能。为了探究不同剂量大豆蛋白对大鼠抗疲劳和运动能力的影响,本研究对SD大鼠灌胃不同剂量(200 mg, 400 mg, 800 mg)的大豆蛋白,4周后对大鼠进行力竭游泳实验,并检测大鼠血液、肝脏和骨骼肌的血糖(Glu)、乳酸(Lac)、尿素氮(BUN)、游离脂肪酸(NEFA)、肌酸激酶(CK)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和丙二醛(MDA)水平。研究显示,补充大豆蛋白可按照剂量依赖方式提高大鼠的力竭游泳时间。补充大豆蛋白可降低大鼠血清的Lac和BUN水平,并提高血清NEFA水平。补充大豆蛋白可降低大鼠血清的CK、AST和ALT水平。补充大豆蛋白可提高大鼠血清SOD及肝脏和骨骼肌组织CAT水平,并降低肝脏和骨骼肌组织中的MDA水平。研究结论初步表明,大豆蛋白可有效提高大鼠的抗疲劳能力、改善能量代谢方式、提高抗氧化能力、减轻运动损伤,从而提高大鼠的运动能力。大豆蛋白补充剂有望成为提高运动员抗疲劳能力和运动能力的功能饮料,具有较高的开发价值。     

秋葵籽油对高强度运动所致肝损伤的保护作用

本研究考察了秋葵籽油对高强度运动所致肝损伤的保护作用及机制。研究显示,对昆明小鼠灌胃不同剂量(10 mg/kg,20 mg/kg和50 mg/kg)的秋葵籽油4周后,秋葵籽油以剂量依赖性方式提高了小鼠的力竭游泳时间(p<0.05)。秋葵籽油降低了小鼠血清乳酸和尿素氮水平,并升高了血清游离脂肪酸和肝糖原水平(p<0.05)。秋葵籽油以剂量依赖性方式提高了小鼠肝脏组织中SOD、CAT和GSH-Px活性,并抑制了MDA的合成(p<0.05)。秋葵籽油抑制了力竭游泳诱导的小鼠血清CK、AST和ALT水平及肝脏组织NO水平的升高(p<0.05)。此外,苏木精和伊红(HE)染色证实了秋葵籽油减轻了力竭游泳诱导的肝脏病理改变。因此,本研究初步结论表明,在高强度运动过程中,秋葵籽油可通过抑制乳酸和尿素氮的积累、增加脂肪动员、降低糖原消耗、减弱氧化应激损伤等多种途径来对肝脏发挥保护作用。     

山葵树叶提取物在力竭运动大鼠中的抗疲劳机制研究

山葵树叶中含有丰富的矿物质和维生素,体外研究证实山葵树叶提取物具有较好的体外抗氧化活性。然而,山葵树叶提取物在体内的抗氧化和抗疲劳作用尚不明确。本研究分别按照100 mg/kg·bw、200 mg/kg·bw和500 mg/kg·bw的剂量对SD大鼠灌胃山葵树叶提取液4周。研究显示,山葵树叶提取物可以剂量依赖性方式提高大鼠的力竭游泳时间(p<0.05)。山葵树叶提取物可显著降低力竭游泳大鼠血清Lac和BUN水平并升高NEFA水平。山葵树叶提取物可提高大鼠的肝糖原和肌糖原含量。山葵树叶提取物可提高大鼠血清和组织SOD、GSH-Px和CAT水平并降低MDA水平。山葵树叶提取物可上调大鼠肝组织中ORM1、CCR5的m RNA和蛋白水平。本研究表明山葵树叶提取物可有效提高力竭游泳大鼠的抗疲劳能力。山葵树叶提取物的抗疲劳作用与减少乳酸堆积、增加脂肪动员、减少糖原分解、提高抗氧化活性有关。此外,山葵树叶提取物的抗疲劳作用与上调ORM1和CCR5的表达有关。     

连续摄入小球藻提取物缓解大鼠运动性心肌损伤研究

为探讨小球藻保护大鼠运动因运动造成的心肌损伤,为小球藻科学合理的应用和推广提供理论依据,本研究将60只SD大鼠随机分为5组:对照组(C组)、运动对照组(S组)、运动+低剂量小球藻组(SCL组)、运动+高剂量小球藻组(SCH组),每组12只大鼠。所有参与实验的大鼠每天自由饮水择食,小球藻的摄入采用灌胃器每日灌胃一次。小球藻各组灌胃体积为5 m L/kg,其他组灌入等量生理盐水。安静对照组(C组)笼内自由活动,不进行额外运动,运动对照组(S组)、运动+低剂量小球藻组(SCL组)、运动+高剂量小球藻组(SCH组)进行8周的跑台跑步训练,每周6次。1~4周进行中等强度训练,5~8周进行高强度训练。本研究发现,在大鼠血清谷丙转氨酶、乳酸脱氢酶、肌酸激酶、α-羟丁酸脱氢酶含量水平,S组较C组均显著升高(p<0.05)。血清谷丙转氨酶、乳酸脱氢酶、肌酸激酶含量,SCL组和SCH组显著低于S组(p<0.05),SCL组和SCH组组间无显著性差异(p>0.05),且随剂量增加而递减。鼠心肌SOD活性方面,S组显著低于C组(p<0.05);SCL组和SCH组显著高于S组(p<0.05),组间随剂量增加而递增;SCH组显著高于SCL组(p<0.05)。血清、心肌CGRP水平,S组显著低于C组(p<0.05);SCL组和SCH组显著低于S组均显著降低(p<0.05)。本研究认为摄入小球藻能够有效消除机体由于长期高强度大负荷运动下产生的过量的自由基;提高机体免疫力,增强血管原生性一氧化氮合酶活性。     

核桃清蛋白抗氧化肽对力竭运动小鼠抗疲劳和抗氧化能力的影响

核桃蛋白是一种具有多种功效的高营养植物蛋白。本研究首先制备了核桃清蛋白抗氧化肽,然后应用不同剂量的核桃清蛋白抗氧化肽灌胃大鼠4周,并用维生素C作为阳性对照,考察了其对力竭运动小鼠抗疲劳和抗氧化能力的影响。研究发现,维生素C和核桃清蛋白抗氧化肽均可显著提高小鼠的游泳力竭时间,且随着核桃清蛋白抗氧化肽溶液浓度的升高,小鼠的力竭时间也随之延长。核桃清蛋白抗氧化肽可以以剂量依赖性方式提高小鼠的肝糖原和游离脂肪酸含量并降低乳酸和尿素氮含量。随着核桃清蛋白抗氧化肽浓度的升高,小鼠的血清肌酸激酶、天冬氨酸转氨酶和丙氨酸转氨酶水平均逐渐降低。核桃清蛋白抗氧化肽以剂量依赖方式提高小鼠SOD和CAT水平并降低MDA水平。研究证实,核桃清蛋白抗氧化肽具有较好的抗疲劳作用和抗氧化能力,其抗疲劳作用与提高肝糖原储备能力、增加脂肪动员、降低乳酸堆积和蛋白质分解有关。其抗氧化能力与清除自由基和减弱脂质过氧化有关。总之,核桃清蛋白抗氧化肽在营养补充剂方面具有较高的开发和应用前景。     

不同剂量白藜芦醇对糖尿病性白内障大鼠晶状体抗氧化酶活力的影响

目的:探究不同剂量白藜芦醇对糖尿病性白内障大鼠晶状体抗氧化酶活力的影响。方法:75只5周龄健康SPF级雄性SD大鼠按照随机数字表法分为正常对照组、模型组,白藜芦醇低剂量组,白藜芦醇中剂量组和白藜芦醇高剂量组,每组各15只。五组大鼠均给予常规适应性喂养,模型组和白藜芦醇低、中、高剂量组大鼠采用链脲佐菌素(STZ)以60 mg/kg的给药剂量制作糖尿病大鼠模型,成模后白藜芦醇低剂量组按20 mg/kg、白藜芦醇中剂量组按50 mg/kg、白藜芦醇高剂量组按100 mg/kg的给药剂量每日给予白藜芦醇灌胃。观察12周后5组大鼠晶状体的混浊程度,检测血糖、体重后处死大鼠,检测晶状体内超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)以及过氧化氢酶(CAT)的活性改变。结果:随着白藜芦醇剂量的升高,白藜芦醇低、中、高剂量组大鼠的血糖逐渐降低而体重逐渐升高,且组间比较均具有统计学差异(P0.05)。三组不同剂量白藜芦醇干预组大鼠晶状体的浑浊程度均低于模型组,且白藜芦醇高剂量组大鼠晶状体的浑浊程度最低,差异均具有统计学意义(P0.05)。白藜芦醇低、中、高剂量组大鼠SOD、GSH-PX和CAT酶活力与模型组大鼠相比均明显升高,而与正常对照组相比均明显降低(均P0.05)。随着白藜芦醇剂量的升高,白藜芦醇低、中、高剂量组大鼠SOD、GSH-PX和CAT酶活力逐渐升高,且组间比较均具有统计学差异(P0.05)。结论:高剂量白藜芦醇可更为明显地降低血糖浓度,提高晶状体SOD、GSH-Px及CAT酶活力,改善糖尿病性白内障晶状体的浑浊程度。     

白藜芦醇通过调节SIRT1/NF-κB通路减轻力竭训练致大鼠肾的炎症反应

白藜芦醇是天然存在的沉默信息调节因子2相关酶1(sirtuin1,SIRT1)小分子激动剂,其肾的保护作用已在多种肾疾病动物模型中得到了验证。然而,白藜芦醇是否能够改善力竭训练导致的大鼠肾损伤,以及是否通过SIRT1/NF-κB信号通路调节运动性肾损伤大鼠肾炎症反应,尚缺乏系统研究。本研究将32只SD大鼠随机分为安静对照组(Con组),白藜芦醇组(Rsv组),力竭运动组(Ex组),力竭运动+白藜芦醇组(Ex+Rsv组)。Rsv和Ex+Rsv组每天灌胃50 mg/kg体重剂量的白藜芦醇, Ex和Ex+Rsv组进行4周力竭训练,最后1次训练后24 h取材。本研究结果显示,与Con组相比,Ex组大鼠Scr(175.66±16.08 vs.153.34±8.67,P0.01)、BUN(6.67±0.53 vs.5.37±0.19,P0.01)和尿NGAL(9.01±0.18 vs.7.48±0.31,P0.01)水平均显著升高,Ex组大鼠肾组织NF-κB P65在蛋白质水平表达显著升高(0.77±0.10 vs. 0.27±0.03,P0.01);各组大鼠肾组织SIRT1在蛋白质水平表达上,Rsv组显著高于Con组(0.90±0.14 vs. 0.43±0.15,P0.05),Ex+Rsv组显著高于Ex组(1.0±0.28 vs. 0.38±0.12,P0.01);与Ex组相比,Ex+Rsv组大鼠肾组织NF-κB P65(0.57±0.13 vs. 0.77±0.10,P0.05)和Ac-NF-κB P65(0.52±0.13 vs. 0.78±0.11,P0.05)在蛋白质水平表达显著降低。以上结果表明,4周大强度力竭运动导致大鼠出现运动性肾损伤,并激活大鼠肾NF-κB的表达。白藜芦醇可显著提高大鼠肾组织SIRT1在蛋白质水平的表达,并增加脱乙酰化作用,降低NF-κB P65蛋白质乙酰化修饰水平,进一步降低NF-κB的表达。白藜芦醇减轻力竭训练致大鼠肾的炎症反应的机制可能与SIRT1/NF-κB通路有关。     

白藜芦醇通过调节SIRT1/NF-κB通路减轻力竭训练致大鼠肾脏炎症反应

白藜芦醇是天然存在的沉默信息调节因子2相关酶1(sirtuin1，SIRT1)小分子激动剂，其肾的保护作用已在多种肾疾病动物模型中得到了验证。然而，白藜芦醇是否能够改善力竭训练导致的大鼠肾损伤，以及是否通过SIRT1/NF κB信号通路调节运动性肾损伤大鼠肾炎症反应，尚缺乏系统研究。本研究将32只SD大鼠随机分为安静对照组(Con组)，白藜芦醇组（Rsv组），力竭运动组（Ex组），力竭运动+白藜芦醇组（Ex+Rsv组）。Rsv和Ex+Rsv组每天灌胃50 mg/kg体重剂量的白藜芦醇， Ex和Ex+Rsv组进行4周力竭训练，最后1次训练后24 h取材。本研究结果显示，与Con组相比，Ex组大鼠Scr（175.66 ± 16.08 vs.153.34 ± 8.67，P < 0.01）、BUN（6.67 ± 0.53 vs.5.37 ± 019，P < 0.01）和尿NGAL（9.01 ± 0.18 vs.7.48 ± 0.31，P < 0.01）水平均显著升高，Ex组大鼠肾组织NF κB P65在蛋白质水平表达显著升高（0.77 ± 010 vs. 0.27 ± 0.03，P < 0.01）；各组大鼠肾组织SIRT1在蛋白质水平表达上，Rsv组显著高于Con组（0.90 ± 0.14 vs. 0.43 ± 0.15，P < 0.05），Ex+Rsv组显著高于Ex组（1.0 ± 0.28 vs. 0.38 ± 0.12，P< 001）；与Ex组相比，Ex+Rsv组大鼠肾组织NF-κB P65（0.57 ± 0.13 vs. 0.77 ± 0.10，P < 0.05）和Ac-NF-κB P65（0.52 ± 0.13 vs. 0.78 ± 0.11，P < 0.05）在蛋白质水平表达显著降低。以上结果表明，4周大强度力竭运动导致大鼠出现运动性肾损伤，并激活大鼠肾NF-κB的表达。白藜芦醇可显著提高大鼠肾组织SIRT1在蛋白质水平的表达，并增加脱乙酰化作用，降低NF-κB P65蛋白质乙酰化修饰水平，进一步降低NF-κB的表达。白藜芦醇减轻力竭训练致大鼠肾的炎症反应的机制可能与SIRT1/NF-κB通路有关。     

Influence of resveratrol on liver fibrosis induced by dimethylnitrosamine in male rats

Liver fibrosis is a significant health problem which represents the liver’s scarring process and response to injury through deposition of collagen and extracellular matrix, and ultimately leads to cirrhosis. Resveratrol is a naturally occurring phytoalexin found predominantly in grapes. This study aimed to investigate the antifibrotic role of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were divided into four groups and treated for three weeks; control, resveratrol administered orally (20 mg/kg daily), DMN intraperitoneally injected (10 mg/kg 3 days/week), and the last group was pre-treated daily with resveratrol then injected with DMN, 3 days/week. DMN administration induced severe liver pathological alterations. However, oral administration of resveratrol before DMN significantly prevented the induced loss in body weight, as well as the increase in liver weight which arise from DMN administration. Resveratrol has also inhibited the elevation of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and bilirubin levels. Furthermore, resveratrol significantly increased hepatic reduced glutathione (GSH) levels and reduced the levels of malondialdehyde (MDA) due to its antioxidants effect as well as increased serum protein levels. In addition, DMN induced elevation in hydroxyproline content. On the other hand, hydroxyproline level was significantly reduced in the resveratrol pretreated rats. Resveratrol has also remarkably maintained the normal liver lobular architecture. Moreover, resveratrol had displayed potent potentials to prevent collagen deposition, lymphocytic infiltration, necrosis, steatosis, vascular damage, blood hypertention, cholangiocyte proliferation. It can be concluded that resveratrol has a marked protective role on DMN-induced liver fibrosis in rats, and can be considered as antiproliferative, antihypertensive, as well as antifibrotic agent and may be used to block the development of liver fibrosis.     

Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model

The ability of resveratrol to inhibit vascular intimal thickening was tested in an experimental model in which endothelial denudation was performed in the normal rabbit iliac artery. Resveratrol (2 approximately 4mg/ kg/d) was administered intragastrically for 5 weeks beginning 1 week before denudation. At the higher concentration of resveratrol, the intimal hyperplasia of injured vascular wall was effectively inhibited; the intimal proliferation index also was significantly less than that in the untreated control group (0.28 +/- 0.07 vs 0.41 +/- 0.13, respectively, p<0.01); the relative luminal area increased from 0.38 +/- 0.06 in the untreated control group to 0.53 +/- 0.10 in the resveratrol treatment group (p < 0.001); and the count of smooth muscle cells in the thickened intima was statistically significantly reduced in the high dose resveratrol treatment group than that in the untreated group (1,115 +/- 510 vs 1,796 +/- 963, respectively, p < 0.05). Resveratrol added to the culture media of cultured rabbit vascular smooth muscle cells inhibited DNA synthesis in a dose-dependent manner. These results showing that resveratrol is capable of inhibiting intimal hyperplasia of injured artery raise the possibility that this polyphenol might have clinical potential in prevention and treatment of restenosis after angioplasty.     

The deleterious effect of stress‐induced depression on rat liver: Protective role of resveratrol and dimethyl fumarate via inhibiting the MAPK/ERK/JNK pathway

This study aimed to uncover the protective potentiality of resveratrol and dimethyl fumarate (DMF) in the liver of a chronic unpredictable mild stress (CUMS)‐induced depression animal model. Resveratrol and DMF significantly alleviated CUMS‐induced behavioral abnormalities in stressed rats through improving sucrose preference in sucrose preference test and decreasing immobility time in a forced swimming test. They also mitigated serum corticosterone levels and elevated serum serotonin levels, which were formerly disturbed in CUMS rats. The hepatoprotective effect is evidenced by improvement in hepatic histopathological examinations, as well as normalized serum alanine aminotransferase and aspartate aminotransferase activities. Molecular signaling of resveratrol and DMF was estimated by diminishing hepatic expression of phosphorylated p38 mitogen‐activated protein kinase (MAPK), extracellular signal‐regulated kinase1/2 (ERK1/2), and c‐Jun N‐terminal kinase (JNK). Consequently, they improved the hepatic antioxidant and anti‐inflammatory activities as elaborated by the normalization of total antioxidant capacity, glutathione, malondialdehyde, nuclear factor‐κB, tumor necrosis factor‐α, and myeloperoxidase levels. In addition, they inhibited hepatocyte apoptosis as evidenced by the increased expression of B‐cell lymphoma 2, the decreased expression of Bax, as well as the suppressed activity of caspase‐3. In conclusion, resveratrol and DMF purveyed a significant anti‐depressant effect, which may be mediated, at least in part, via inhibiting the MAPK/ERK/JNK pathway in the CUMS rat model.     

The effect of resveratrol on surgery-induced peritoneal adhesions in an experimental model

Adhesion formation is a common cause of complications following surgery. The aim of this study was to investigate the effect of resveratrol on intra-abdominal adhesion prevention in a rat model. Twenty one Wistar-Albino rats weighing 200-250 g were assigned to three groups, of 7 rats each. After a midline laparotomy was performed, a 1 cm area of the ceacum was abraded in two of the groups. They were then given either resveratrol (Group 1), or saline (Group 2) intraperitoneally. Group 3 rats (sham operation) received no treatment, without the serosal damage. On the 14th day, the rats were killed and the adhesion score was determined according to Mazuji's adhesion grade scale. The tissue levels of malondialdehyde (MDA), nitric oxide (NO), and reduced glutathione (GSH) were measured. The mean Mazuji's adhesion grade in the resveratrol group was 1.0 +/- 0.0, in the saline group 2.57 +/- 1.51, and zero in the sham operated group (p < 0.05 between the resveratrol group and saline group comparison). The levels of MDA and NO in the resveratrol group were significantly lower than those of the saline group (p < 0.001). The level of GSH in the resveratrol group was significantly higher than in the saline and sham operated groups (p < 0.001 and p < 0.001, respectively). Introduction of resveratrol into the peritoneal cavity at the time of surgery reduced adhesion formation effectively in this model. Resveratrol probably acts through reduction of lipid peroxidation products.     

白藜芦醇对大鼠局灶性脑缺血再灌注的治疗作用

目的:观察白藜芦醇对大鼠局灶性脑缺血再灌注损伤的治疗作用及可能的机制。方法:将SD大鼠随机分为2组:对照组(n=16),白藜芦醇组(n=16)。对照组再灌注即刻腹腔给予0.5 ml生理盐水,白藜芦醇组再灌注即刻腹腔给予20 mg/kg白藜芦醇。再灌注22小时后,进行神经功能学评分、脑梗死容积测定,用分光光度仪测定脑组织溶浆中SOD、MDA和MPO的含量。结果:再灌注22小时后,白藜芦醇治疗组可以改善大鼠神经功能学评分和降低脑梗死面积(P<0.05),同时可以增加脑组织溶浆中SOD的活性,降低MDA和MPO的含量。结论:白藜芦醇通过减轻白细胞的浸润、提高自由基的清除率对大鼠局灶性脑缺血再灌注损伤发挥治疗作用。     

Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats

Advanced glycation end-products (AGEs) of plasma proteins and/or matrix proteins are candidate mediators for various vascular complications such as atherosclerosis. We previously reported a significantly larger accumulation of AGEs of the aorta in stroke-prone spontaneously hypertensive rats (SHRSP) than in age-matched Wistar-Kyoto rats (WKY). In this study, we examined the effects of AGEs on vascular smooth muscle cells (VSMC) from SHRSP and WKY rats. We also studied the in vitro effects of resveratrol (3, 4',5-trihydroxystilbene), a natural phytestrogen, on VSMC proliferation, DNA synthesis, and collagen synthesis activity in SHRSP-VSMC. AGEs accelerated the proliferation of SHRSP- or WKY-VSMC in a time- and dose-dependent manner. VSMC from SHRSP were more sensitive to AGEs than VSMC from normotensive WKY. AGEs also significantly increased DNA synthesis and prolyl hydroxylase activity, a marker for collagen synthesis, in SHRSP-VSMC. AGEs-induced increases in TGF-beta1 mRNA in SHRSP-VSMC were significantly greater than in WKY-VSMC. Resveratrol inhibited AGEs-stimulated proliferation, DNA synthesis, and prolyl hydroxylase activity in SHRSP-VSMC in a dose-dependent manner. ICI 182780, a specific estrogen receptor antagonist, partly blocked the inhibitory effects of resveratrol on AGEs-stimulated proliferation, DNA synthesis, and prolyl hydroxylase activity. Resveratrol significantly inhibited AGEs-induced TGF-beta1 mRNA increases in a dose-dependent manner. Thus, resveratrol may confer protective effects on the cardiovascular system by attenuating vascular remodeling and may be clinically useful as a safer substitute for feminizing estrogens in preventing cardiovascular disease.     

Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations

The dietary polyphenolic compound resveratrol, by activating the protein deacetylase enzyme silent information regulator 2/sirtuin 1 (SIRT1), prolongs life span in evolutionarily distant organisms and may mimic the cytoprotective effects of dietary restriction. The present study was designed to elucidate the effects of resveratrol on cigarette smoke-induced vascular oxidative stress and inflammation, which is a clinically highly relevant model of accelerated vascular aging. Cigarette smoke exposure of rats impaired the acetylcholine-induced relaxation of carotid arteries, which could be prevented by resveratrol treatment. Smoking and in vitro treatment with cigarette smoke extract (CSE) increased reactive oxygen species production in rat arteries and cultured coronary arterial endothelial cells (CAECs), respectively, which was attenuated by resveratrol treatment. The smoking-induced upregulation of inflammatory markers (ICAM-1, inducible nitric oxide synthase, IL-6, and TNF-alpha) in rat arteries was also abrogated by resveratrol treatment. Resveratrol also inhibited CSE-induced NF-kappaB activation and inflammatory gene expression in CAECs. In CAECs, the aforementioned protective effects of resveratrol were abolished by knockdown of SIRT1, whereas the overexpression of SIRT1 mimicked the effects of resveratrol. Resveratrol treatment of rats protected aortic endothelial cells against cigarette smoking-induced apoptotic cell death. Resveratrol also exerted antiapoptotic effects in CSE-treated CAECs, which could be abrogated by knockdown of SIRT1. Resveratrol treatment also attenuated CSE-induced DNA damage in CAECs (comet assay). Thus resveratrol and SIRT1 exert antioxidant, anti-inflammatory, and antiapoptotic effects, which protect the endothelial cells against the adverse effects of cigarette smoking-induced oxidative stress. The vasoprotective effects of resveratrol will likely contribute to its antiaging action in mammals and may be especially beneficial in pathophysiological conditions associated with accelerated vascular aging.